Cholestenoic acid, an endogenous cholesterol metabolite, is a potent γ-secretase modulator

BACKGROUND: Amyloid-β (Aβ) 42 has been implicated as the initiating molecule in the pathogenesis of Alzheimer’s disease (AD); thus, therapeutic strategies that target Aβ42 are of great interest. γ-Secretase modulators (GSMs) are small molecules that selectively decrease Aβ42. We have previously repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Joo In, Price, Ashleigh R., Ladd, Thomas B., Ran, Yong, Park, Hyo-Jin, Ceballos-Diaz, Carolina, Smithson, Lisa A., Hochhaus, Günther, Tang, Yufei, Akula, Rajender, Ba, Saritha, Koo, Edward H., Shapiro, Gideon, Felsenstein, Kevin M., Golde, Todd E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501119/
https://www.ncbi.nlm.nih.gov/pubmed/26169917
http://dx.doi.org/10.1186/s13024-015-0021-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501119/
https://www.ncbi.nlm.nih.gov/pubmed/26169917
http://dx.doi.org/10.1186/s13024-015-0021-z

Ejemplares similares